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Background: Anxiety and mood disorders are highly prevalent and pose a huge burden on patients. Their offspring
is at increased risk of developing these disorders as well, indicating a clear need for prevention of psychopathology
in this group. Given high comorbidity and non-specificity of intergenerational transmission of disorders, prevention
programs should target both anxiety and depression. Further, while the indication for preventive interventions is
often elevated symptoms, offspring with other high risk profiles may also benefit from resilience-based prevention
programs.
Method/design: The current STERK-study (Screening and Training: Enhancing Resilience in Kids) is a randomized
controlled clinical trial combining selected and indicated prevention: it is targeted at both high risk individuals
without symptoms and at those with subsyndromal symptoms. Individuals without symptoms meet two of three
criteria of the High Risk Index (HRI; female gender, both parents affected, history of a parental suicide (attempt). This
index was developed in an earlier study and corresponds with elevated risk in offspring of depressed patients.
Children aged 8–17 years (n = 204) with subthreshold symptoms or meeting the criteria on the HRI are randomised
to one of two treatment conditions, namely (a) 10 weekly individual child CBT sessions and 2 parent sessions or (b)
minimal information. Assessments are held at pre-test, post-test and at 12 and 24 months follow-up. Primary
outcome is the time to onset of a mood or anxiety disorder in the offspring. Secondary outcome measures include
number of days with depression or anxiety, child and parent symptom levels, quality of life, and cost-effectiveness.
Based on models of aetiology of mood and anxiety disorders as well as mechanisms of change during
interventions, we selected potential mediators and moderators of treatment outcome, namely coping, parent–child
interaction, self-associations, optimism/pessimism, temperament, and emotion processing.
Discussion: The current intervention trial aims to significantly reduce the risk of intergenerational transmission of
mood and anxiety disorders with a short and well targeted intervention that is directed at strengthening the
resilience in potentially vulnerable children. We plan to evaluate the effectiveness and cost-effectiveness of such an
intervention and to identify mechanisms of change.
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Anxiety disorders are highly prevalent among children
and adolescents with estimates of 11.6% year prevalence
in adolescents alone [1], and depression is highly preva-
lent among adolescents, with estimates of 3.8% year
prevalence [1]. Anxiety and mood disorders in childhood
and adolescence not only have a high impact on present
functioning [2,3], but are also associated with long-term
negative consequences [4,5]. In the Netherlands alone,
estimations are that as many as 37.400 adolescents
(3.8%) suffer from depressive disorder [1], corresponding
with a burden of disease of 7900 Disability Adjusted Life
Years (DALYs), meaning that per year 7900 healthy years
are lost due to depression alone in youngsters ‘Gezond
Verstand’, [6]. For anxiety disorders, estimates are
113.000 adolescents (11.6% year prevalence) and 15.000
DALYs.
From epidemiological research, we know that anxiety
and mood disorders often run in families: the incidence
of depression and anxiety is elevated by a factor 2–6
among offspring of patients with such a disorder (e.g.
[7,8]). There is considerable aetiological and phenom-
enological overlap between mood and anxiety disorders.
Anxiety often precedes depression [9] with the age of
onset of depression being typically 5 to 10 years later
than that of anxiety disorders e.g. [10].
Given the high prevalence of anxiety and mood disorders,
the high impact on individuals as well as the associated so-
cietal costs, there is a clear need for prevention of anxiety
and mood disorders in youth. Since these disorders run in
families, the family may be a good starting point for
prevention.
During the last two decades, a variety of programs has
been developed to prevent anxiety disorders or depres-
sion among children and adolescents [overview: 2,11].
The results of universal prevention programs are disap-
pointing for both anxiety and mood symptomatology
[e.g. 2,12]. For selective prevention (targeting high risk
groups) and indicated prevention (targeting those with
subclinical symptoms) results are more promising.
Despite of the relatively high risk in offspring, thus far the
number of randomised controlled trials testing the efficacy
of indicated prevention is very limited: Four randomised
trials have aimed at offspring of depressed patients [13-16],
with two studies reporting on cognitive behavioural group
treatments for offspring, and two studies including more
family-based treatments. Only one study reported on pre-
vention in children of anxiety disordered parents [17].
In the first study, the effectiveness of the 15-session cog-
nitive group training ‘Coping with stress’ was examined in
adolescent offspring of a depressed parent [13]. Adoles-
cents (N=94) were aged 13–17 years and had subclinical
depressive symptoms or a history of depression them-
selves. The program encompassed cognitive restructuringtechniques aimed at changing maladaptive thoughts in
general and dysfunctional thoughts with regard to having a
depressed parent. The intervention was not only effective
in reducing depressive symptomatology, but also showed a
significant reduction of new depressive episodes relative to
care as usual. The program was also cost-effective [18].
Second, Garber and colleagues designed the largest
multicenter trial in this field, including 316 youngsters
aged 13–17 years. They were offspring of a parent with a
current or prior depressive disorder, and had had a de-
pression themselves or reported depressive symptoms.
Adolescents were randomized to either care as usual or
an 8-session CBT group training existing of cognitive re-
structuring and problem solving. Parents were invited to
two parent information sessions. Adolescents were less
likely to suffer from a depressive episode if they had
received the training (21% versus 32% onset in 6 months),
but only if the parent was remitted at the time of the
intervention.
The third study investigated the effectiveness of a fam-
ily program, including the 8–15 year-old offspring of at
least one parent with an episode of depression in the
past 18 months [16]. At least one of the children in the
family needed to be free of a depressive disorder. The
6–11 session family program was compared to two plen-
ary group lectures for parents. Both interventions advo-
cated open discussion about the parental illness and
were directed at change in family dynamics. Both inter-
ventions proved equally effective in increasing family func-
tioning and decreasing internalising behaviours up to
4.5 year follow-up (based on 105 families) [18]. Families in
the more intensive treatment reported more benefits in
parent-child behaviours and regarding the child’s under-
standing of parental mental illness.
The fourth trial also investigated the effectiveness of a
family intervention for families with at least one parent
with a history of depression [19]. The children did not
need to report symptoms themselves to participate in the
study. Participants included 111 families with 155 children
aged 9–15 years, who were randomized to either written
information only or to a 12-session cognitive behavioral
family intervention in a group format [19]. The family
intervention focused on enhancing awareness of the role
of depression in a family, on ameliorating parent–child
interactions by teaching parenting skills (focusing on par-
ental warmth and structure), and on learning general cop-
ing skills (for parents and children separately). Results
indicate that children in the family program showed more
benefits in terms of internalizing and externalizing symp-
toms in both parent and child reports. These gains were
maintained at two year follow-up [20].
The only trial so far focusing on offspring of patients
with anxiety disorders included 40 children aged 7–
12 years, who were randomized to either an 8-session
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strengths or to a waitlist control condition. Children were
not allowed to have a current anxiety disorder. Current or
past symptomatology was not warranted for inclusion in
the study. This trial was successful in preventing the onset
of anxiety disorders in the offspring: offspring in the active
condition did not develop anxiety disorders, whereas 30%
of waitlist children met criteria for an anxiety disorder at
1 year follow-up.
In conclusion, results on interventions for offspring
of depressed patients (4 studies) and anxious patients
(1 study) were positive overall, including benefits on
offspring symptomatology [20,21], offspring onset of
disorder [13,14,17,20], parent-child interaction [21],
and offspring knowledge on the parent’s illness [21].
The current study builds upon these studies, while
adding to them in a variety of ways: (1) we use add-
itional risk factors to select ultra high risk individuals
among offspring of patients with a mood or anxiety dis-
order; (2) we focus on both depression and anxiety; (3)
we aim at symptom reduction as well as at increasing
strengths and resilience; (4) we include mediators and
moderators of change; (5) we include short and long-
term cost-effectiveness analyses.
The aforementioned studies were either indicated pre-
vention programs (youth with elevated symptoms) or
selective prevention programs (youth with a high risk
because of parental illness only). In our study, we aim
at combining the two and thus selecting ultra high risk
offspring. In line with earlier studies, we select youth
with current symptomatology (of anxiety or mood). In
addition, we wanted to make a selection of the symptom-
free children. We know that some of the offspring may
develop disorders over time, even though they currently
do not report such symptoms. Recently, we have devel-
oped a prognostic index that predicts the development
of anxiety or mood disorders in offspring (High Risk
Index (HRI; de Vries, Landman-Peeters, Burger, Reichart,
Nauta, den Boer, Nolen, Ormel, & Hartman: Predicting
mood- and anxiety disorders in offspring of patients with
a depressive disorder, unpublished manuscript)). This
was done on the basis of a study examining offspring
(n = 434) of patients with a unipolar mood disorder in a
large prospective study, the ARIADNE-cohort (Adoles-
cents at Risk of Anxiety and Depression, and Neurobio-
logical and Epidemiological approach [22]). Three factors
were associated with an increased risk of developing anx-
iety or mood disorders: female sex, having two affected
parents, and suicide attempt(s) of one of the parents. In
children with two or three risk factors (20% of the sam-
ple) the cumulative incidence of mood and anxiety disor-
ders was 70% at the age of 20. In children with one or
no risk factor, percentages dropped to 45% and 25% re-
spectively. In the current study, inclusion is thereforebased on the HRI as well as on symptomatology.
Thereby, this study uniquely combines selected and indi-
cated prevention [23].
For this group of high-risk offspring, we developed an
individual cognitive behavioural therapy (CBT) based
intervention targeting multiple risk and protective factors
known to be associated with the onset of anxiety and de-
pression (as recommended by Cuijpers [24]). Many pre-
vention programs have focused on symptom reduction,
whereas training of positive aspects and building resilience
may be of utmost importance in prevention. Some at risk
children may not show any symptomatology yet, and they
may especially benefit from interventions focusing on
strengths rather than vulnerabilities. Important protective
factors in offspring include having knowledge on parental
illness [25], having a supportive social network [22,26] in-
cluding a non-ill parent if available [27], as well as display-
ing active coping skills and flexibility in coping style across
situations [28]. Therefore, the offspring intervention
includes psychoeducation for offspring, psychoeducation
for parents, a focus on the social network, and problem
solving skills training. With regard to the risk factors, we
know that offspring may have a cognitive vulnerability in
information processing: they report more negative and less
positive self-statements [29]. Interventions focusing on
positive self-statements, positive emotions and positive
events may enhance resiliency and may function as a buf-
fer against developing negative mood or anxious feelings.
A final risk factor are subclinical complaints. These symp-
toms are addressed by regular behavioural interventions,
namely exposure exercises for anxiety and behavioural ac-
tivation for depressive symptoms. Behavioural activation
may be of particular importance, since engaging in activ-
ities and relationships outside of the home environment
has been found to be an important protective factor in
adolescent offspring [25].
So far, most prevention interventions were group-
based. Individual programs allow for more tailoring to
the specific needs, strengths and weaknesses of the child.
This is crucial because of the heterogeneity of the target
population (children with anxiety, or depressive symp-
toms, or no symptoms but an elevated score on the High
Risk Index). In addition, living with a depressed suicidal
parent differs in many ways from living with anxious
dependent one, for example. An individual approach
allows the therapist to tailor the intervention also to the
specific background of the child.
To date, preventive interventions have been designed
to prevent either mood disorders or anxiety disorders.
Keeping in mind the significant overlap in symptoms be-
tween depression and anxiety disorders, prevention stud-
ies should focus on both. Indeed, epidemiological studies
have found that elevated symptoms of anxiety and de-
pression occur in offspring of both anxious [30] and
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genesis of anxiety and depression also have considerable
overlap, including offspring from patients with both
mood and anxiety disorders provides the opportunity to
study common mediating factors.
From a societal point of view, it is important to study
the economic impact of psychiatric illnesses and possible
effects of prevention programs, to assist future policy mak-
ing and resource allocation. The economic evaluation in
our study will focus on the differential effects on short and
long term costs and health outcomes of the treatment con-
ditions under study: CBT or minimal information. The
study will be conducted from a societal perspective [32].
Treatment outcome studies typically include variables to
study the treatment mechanisms (“how does the treatment
work”) as well as the moderators of treatment outcome (“for
what groups does the treatment work”)[33]. With regard to
mediating factors in the current study, the intervention will
aim at changing coping behaviour [34], increasing activities
[35], and enhancing trust in the availability of attachment
figures (in the social network). Even though we do not ad-
dress cognitions directly through cognitive restructuring, we
nonetheless want to investigate if the child’s attributional
style changed through our behaviour intervention.
Moderating factors associated with (non)response are
current parental psychopathology [14] and child’s symp-
tomatology (internalising and externalising). We add-
itionally measured some stable child characteristics that
have been associated with the onset of anxiety or mood
disorders, but have not been studied in relation to treat-
ment outcome in offspring, namely reactive and regula-
tive temperament [36], general executive functioning,
and automatic self-associations [37]. In addition, some of
the presumed mediating factors may also function as
moderators.
In summary, even though there is extensive evidence for
the intergenerational transmission of anxiety and mood
disorders, few preventive intervention studies in offspring
have been carried out. Our study adds to the current state
of the art in combining selective and indicative prevention,
to focus on both anxiety and mood disorders in adult
patients, to focus on both anxiety and depression symp-
toms in offspring, to work on both symptom reduction
and resilience, to study cost-effectiveness, and to examine
mediators and moderators of outcome.
Trial objective and purpose
The primary goal is to investigate whether a brief (10 + 2
sessions) cognitive behavioural treatment program on re-
silience and symptom reduction can prevent the inci-
dence of depression or anxiety disorder in an ultra high
risk sample of 8–18 year old offspring of patients with
unipolar depression or anxiety disorder (sample defined
by a High Risk Index or subclinical symptoms, or both).The second goal is to examine whether this intervention
meets current standards for cost-effectiveness. A third
goal is to explore the role of a number of factors that
may potentially mediate or moderate the effect of the
intervention. Mediating factors include coping, attribu-
tional style, daily activities, and optimism, while the
selected moderating variables are child temperament
characteristics and executive functioning, parental psy-
chopathology (of both parents), child symptomatology,
attachment, and (automatic) self-associations.
Methods/design
The present project is designed as a selected and indi-
cated prevention program: children and adolescents at
high risk for developing affective disorders will be identi-
fied and treated if they run an ultra high risk. Such an
approach results in a relatively powerful design [24]. The
study is further designed as a randomised controlled trial
(RCT), including an intervention condition and a min-
imal information condition.
Participants
Participants in the study are children of patients with
and anxiety or mood disorder. We aim at screening 554
children (T0), and at including 204 children in the inter-
vention phase of the study. We have designed in- and
exclusion criteria for parents and children:
Inclusion criteria (parents):
At least one of the biological parents, currently or in
the past five years, treated for a unipolar mood disorder
or an anxiety disorder; informed consent.
Exclusion criteria (both parents):
Mental retardation; severe alcohol or substance use
disorder; schizophrenia or other primary psychotic dis-
order; schizoaffective disorder; bipolar disorder.
Inclusion criteria for the intervention phase (offspring):
age 8–17; being at ultra high risk for developing a mood
or anxiety disorder. Two pathways lead to the qualifica-
tion of “ultra high risk”: (1) children report elevated
symptoms of anxiety or depression, as defined as the 80th
percentile of either the subscale Depression or the cluster
of subscales of Anxiety on the RCADS self-report. We
used data from the large Dutch epidemiological study
TRAILS to set these cut-offs at the various age segments
(Tracking Adolescents’ Individual Lives [38]). (2) Chil-
dren meet at least 2 of 3 criteria of our High Risk Index
that was developed in the ARIADNE sample: (a) being fe-
male, (b) having two affected parents, (c) having a parent
with (past) suicidal behaviour.
Exclusion criteria (offspring): mental retardation; not
speaking Dutch fluently; severe alcohol or substance use
disorder; current diagnosis of a mental disorder that war-
rants regular treatment. Children with a history of a
mental disorder are included, as well as children with a
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the case of stable medication for ADHD).Procedure
The study has two phases, namely the screening phase
and the intervention phase. Details on the procedure are
described in the flow diagram (Figure 1).Does the parent meet the screen
are both parents and children wil
informed consent?
Screening measures (T0): 
High Risk Index (HRI) questions
A researcher checks whether informed consen
children sign informed consent
Randomisation take
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Figure 1 Flow diagram.Referral and recruitment
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participate in the study.
Informed consent
Adult patients are informed about the study in two ways.
First, patients within a mental health care centre (adult
or youth) are informed about the study by their therapist
by a full information letter, containing all information for
both the parents and the children. If the patient is inter-
ested in participating, he or she can contact the re-
searcher. The researcher then checks whether the family
has understood the information on the trial. If so, the
consent form is signed by both parents and children, and
the family is invited for the first screening. Separate
informed consent forms are available for parents, adoles-
cents (secondary school) and children (primary school).
Even though informed consent is not warranted under
the age of 12 in the Netherlands, we do have younger
children sign informed consents so that we are sure they
are fully informed about the study.
Second, patients may contact the researchers directly,
after having received information about the study via their
general practitioner, the media, or the website. In that case,
the researcher directly informs the family members about
the study by way of the information letters described above.
We then check the status parent’s past and current psycho-
pathology through a brief telephone interview. Note that
for all parents the exact diagnosis is obtained during the
assessments through a structured diagnostic interview
(CIDI).
Participants can always draw back from participating in
the study, at any time during the assessment or interven-
tion, without giving a reason for their withdrawal. With-
drawal from the trial will not affect the regular mental
health care for either themselves or their children.
Randomisation
Since outcome may be dependent on treatment centre
and the pathway of inclusion (through elevated symp-
toms versus no symptoms/HRI only), we decided to
work with stratified allocation to treatment condition to
ensure a balanced number of participants over condi-
tions. A web-based computer program allows for dy-
namic on-the-spot randomisation. Randomisation is
based on the defined strata as well as on the assigned
treatment condition of earlier subjects within the strata.
To prevent conscious or unconscious influence on the
recruiting team, we choose to conceal the exact details
of the randomisation process at this stage (following the
recommendations of the CONSORT guidelines [39]).
Randomisation takes place after the whole assessment
has been completed, so that the first assessment is not
dependent on the participant’s knowledge of treatment
condition. The research assistant assigns a unique codeto each participant. In case one family has several high
risk children, the youngest child is entered for random-
isation, and the siblings are assigned to the same condi-
tion. The research assistant then enters the number of
the participant in the web-based randomisation program,
and at that moment the computer randomly assigns the
treatment condition (active intervention or minimal in-
formation; 1:1).
Intervention
The intervention has 10 child sessions and 2 sessions for
the parents. To strengthen the effectiveness of our inter-
vention, it is based on a theoretical framework including
both risk and protective factors (as recommended by
Cuijpers [24]).The following themes are addressed: family
functioning and social network, being proud of strengths,
focus on positive emotions and events, problem solving,
and breaking the cycle of avoidance behaviour. The latter
will either be focussed on behavioural activation (indica-
tion for depressive symptoms [35]) or on exposure exer-
cises (indication for anxiety symptoms). The therapist
addresses each of the themes in the first sessions and
then elaborates on the most appropriate module(s) for
each child. In collaboration with the child and the par-
ents, the child chooses 10 steps to work on throughout
the sessions. These steps are in line with the aforemen-
tioned themes, and could encompass engaging in specific
activities, exposure exercises, and exercises on strengths
and resilience. Throughout the sessions, the child regu-
larly monitors the frequency and type of activities (cate-
gorised as either alone or with others, and either at home
or elsewhere). Ideally, children should have satisfying ac-
tivities in each of these four categories. This registration
is available for mediation analyses. The first session is
with the parents only. The therapist makes a plan with
the parents on how to give age-appropriate information
on the parental anxiety or mood disorder to the child in
the next session. Parents also receive information on the
possible effect on offspring and protective factors against
future child psychopathology (such as having a parent or
key figure they can trust, and openness in the family).
Two more parent sessions further elaborate on positive
parenting and defining the social network in terms of so-
cial support for the family.
Assessments
Assessment schedule
Baseline assessment takes place at T0 and comprises ques-
tionnaires on the child’s and the parent’s wellbeing (see
Table 1). This first screening is used to define the high-risk
study population. At T4, all children of parents that were
willing to participate will be assessed again with the same
measures. The latter is important to evaluate the validity
of the initial selection of high risk individuals. If a relatively
Table 1 Assessment schedule for screening (T0) and
24 months follow-up screening
Measures Child Parent 1 Parent 2
Demographics (+ HRI) X
Child anxiety and depression (RCADS) X X
Child impairment (BIS) X
Child externalizing symptoms (SNAP) X
Parent positive and negative affect (PANAS) X X
Optimism (LOT/YLOT) X X X
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developed a mood or anxiety disorder, this would imply
that for future prevention programs the selection strategy
should be reconsidered. Selection for the intervention
phase is based on the HRI and the RCADS (see Figure 1).
If a child qualifies for “ultra high risk” based on the
screening, he or she may enter the intervention phase of
the study. The pre-intervention assessment encompasses
structured diagnostic interviews with the child and both
parents, as well as a number of relevant other measures
(see Table 2). Assessments in the intervention phase areTable 2 Assessment schedule for intervention phase
Measures T1 T2
Child diagnoses (DISC) X -
Child anxiety and depression (RCADS) X X
Child impairment (BIS) X X
Child externalizing symptoms (SNAP) X X
Child attachment (IPPA) X X
Implicit child attachment (ABT) X -
Child coping (CSLK) X X
Child attributions (CASQ) X X
Child optimism (YLOT) X X
Child self-esteem (RSES) X X
Expressed emotion (FMSS) X -
Implicit Self-associations (EAST) X -
Child executive functions (BRIEF) X -
Child temperament (EATQ) X X
Parent positive and negative affect (PANAS) X X
Parent depression (BDI) X X
Parent anxiety (BAI) X X
Parent substance misuse (AUDIT) X X
Parent optimism (LOT) X X
Parent psychopathology (CIDI) X -
Cost Effectiveness* X X
Quality of life (EQ-5D)* X X
* Cost effectiveness measures and EQ-5D will also be administered at 6 and 18 mon
Note that T1 = pre-intervention, T2 = 4 months follow-up, T3 = 12 months follow-up,planned for month 0 (T1, at the start of the intervention),
month 4 (T2), month 12 (T3), and month 24 (T4). A subset
of the instruments is also scheduled for month 6 and 18.
Measures
Primary outcome Our primary outcome is the time to
onset of depression or anxiety disorders in the offspring,
based on the Child version of Diagnostic Interview
Schedule for Children Version IV NIMH DISC-IV; [40],
which is a highly structured diagnostic assessment instru-
ment designed to gather symptom presence for child and
adolescent psychiatric disorders based on the symptoms
and criteria variables as defined in the Diagnostic and Stat-
istical Manual of Mental Disorders DSM-IV; [41]. The
computerized DISC is administered via a computer (the
interviewer reads questions from the computer screen and
enters responses directly into the computer) and scored by
computer algorithm [42]. There are parallel versions of the
instrument: the DISC-P for parents, and the DISC-C for
direct administration to children. In the present study the
DISC-C is used to assess anxiety disorders and depression,
and a brief assessment of alcohol and drug use. The DISC-
P is used as a parent report of children’s anxiety andT3 T4 Child Parent1 Parent2
X X X X -
X X X X -
X X X - -
X X X - -
X X X - -
- - - - -
X X X - -
X X X - -
X X X - -
X X X - -
- - - X X
- - - - -
- - - X -
X X - X -
X X - X X
X X - X X
X X - X X
X X - X X
X X - X X
- - - X X
X X - X X
X X X X X
ths.
and T4= 24 months follow-up.
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symptomatology. At the 12- and 24-follow-up assess-
ments, the interviewer addresses the past 12 months. If
any disorder was present, the interviewer makes an esti-
mation of the time of onset and the duration of the dis-
order. The interviewer combines information retrieved
from the DISC with the Weekly Emotions Diary for
Youth (WEDY; Festen & Nauta, Weekly Emotions Diary,
unpublished manuscript) as input. All children included
in the intervention trial are asked to keep a weekly diary
during the study, giving scores of three items: anxiety, sad
mood, and happiness on a 0–5 scale. This chart was
developed for the purpose of the current study, primarily
as a helpful tool to obtain a good estimate of the onset
and duration of a disorder (if present by DISC-criteria),
since children may not always have an adequate sense of
time when retrospectively reporting over the past year.
Children are encouraged to fill out the diaries either on
paper or through the internet in a web-based diary. They
receive an incentive of 1 euro per month for completing
the weekly diary, with a maximum of 25 euros.
Secondary outcomes As secondary outcomes to our
study, we will investigate the number of days with a dis-
order (based on the DISC-IV), child and parent anxiety and
depressive symptoms, quality of life, and cost-effectiveness.
The Revised Child Anxiety and Depression Scale
(RCADS; RCADS; [43]) is a 47-item self-report and a
parent-report questionnaire, with scales corresponding
to separation anxiety disorder, social phobia, generalized
anxiety disorder, panic disorder, obsessive-compulsive
disorder and major depressive disorder.
The Inventory of Depressive Symptomatology IDS;
[44] is a 30-item measure of depressive signs and symp-
toms in adults. In the current study the Dutch translation
of the self-report (SR) version was used to assess current
depressive symptoms of the parents
The Beck Anxiety Inventory BAI; [45] is a 21-item
self-report instrument that assesses the overall severity of
anxiety in adults. In this study the BAI is used to assess
current anxiety symptoms of parents.
To assess quality of life, we included the EuroQol
(EQ-5D [46]), being a brief, easy to administer question-
naire comprised of 2 components: a description of the
respondent’s own health using a health status classifica-
tion system with 5 items and a rating of “own health”
by means of a visual analogue scale (VAS; 0–100). We
included a child version, a parent version and a regular
adult self-report in the current study.
Information on healthcare consumption will be regis-
tered with a comprehensive questionnaire capturing
(mental) healthcare consumption and other illness-
related economic consequences for society. The instru-
ment is administered to the parents and assesses variouscost aspects of the child and each parent, including con-
tacts with healthcare professionals, informal care and ab-
sence from school or work. The instrument is a revision
and adjustment of the youth care version of the TIC-p
[47] and has been adopted to the specific situation of the
current study. The intervention costs are also monitored
including therapist time spent on the actual intervention,
the preparation of sessions, course material, travelling
costs, and the costs of the training of the therapists.
Mediators and moderators of change To examine po-
tential mediators and moderators of change we assessed
the following measures focused on child characteristics
and parent characteristics:
Measures on the child’s characteristics
The Youth Life Orientation (YLOT; [48]) is a 12-item
measure of dispositional optimism and pessimism that
was developed as a child analogue of the widely used Life
Orientation Test.
The Children’s Attributional Style Questionnaire -
Revised CASQ-R; [49] is a 24-item shortened measure
designed to assess children’s causal explanations for posi-
tive and negative events.
The Rosenberg Self-Esteem Scale RSES; [50] is devel-
oped as a 15-item self-esteem scale for children and
adults and translated into different languages.
An Extrinsic Affective Simon Task (EAST; [51]) is a
computerized reaction time task to indirectly measure
attitudes. The current EAST was designed for this study
and intends to assess the strength of the children’s auto-
matic associations between themselves and sad (or
happy) mood, as well as anxious (or calm) feelings. It is a
categorization task, during which target words like “my-
self”, “them”, “anxious”, or “table” appear in the middle of
the computer screen, and children have to assign the tar-
get words to one of the target labels (me, not-me, feeling,
or object) that are set at either the left or the right side of
the screen. In correspondence, children press a right or
left response key as quickly as possible. The underlying
principle is that a person will be faster in categorizing
anxiety or depression words to the key that is defined as
both “feeling” and “me” label if the person regards him or
herself as anxious or depressed. In contrast, the person
may be slower in categorizing the words related to calmth
or happiness to a key that is defined as both a “feeling”
and “me” label. These types of automatic anxious- and
depressed self-associations have been found to be pre-
dictive of symptomatology in adults [37].
The Coping Strategies Checklist for Children CCSC-
R1; Dutch version: CSLK; [52,53] contains 14 subscales, in-
cluding a variety of cognitive coping strategies. Earlier re-
search in offspring has shown that it may be important to
distinguish between coping at home and coping elsewhere
[28]. Therefore, we administered two versions of the
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dimensions (Seeking understanding, Control, Optimism,
Wishful thinking, Support for feeling and Support for
actions).
The Brief Impairment Scale BIS; [54] is a multidimen-
sional scale of functional impairment for children and ado-
lescents. The BIS is a 23-item instrument that evaluates
three domains of functioning: interpersonal relations,
school/work functioning, and self-care/self-fulfillment.
The Behaviour Rating of Executive Functioning
BRIEF; [55] is a 86-item standardized rating scale used to
assess children’s executive functions in home and school
environments. The Early Adolescent Temperament
Questionnaire – Revised version (EATQ-R; [56]) is a par-
ent-report questionnaire that was developed to measure
child temperamental aspects associated with self-regulation.
Three factors were included in the present study with a
total of 44 items, namely Effortful control (including activa-
tion control, attentional control, and inhibitory control),
Negative affect (including Fear, Frustration, and Shyness)
and High intensity pleasure/Surgency.
The SNAP-IV Parent Rating Scale (SNAP; [57]) is a
parent report questionnaire including 18 items for
ADHD (inattention and hyperactivity/impulsivity) and 8
items for ODD symptoms.
The Dutch version of the Inventory of Parent and
Peer Attachment IPPA; [58,59] is an 11-item self-report
instrument that is used to assess attachment to each par-
ent and one significant other.
Mother-child attachment was also administered
through a computer task, the Attentional Breadth Task
[60], that was programmed in e-prime. The task is based
on the assumption that information processing may be
distorted in individuals with insecure attachment when
it comes to attachment-relevant information. Insecurely
attached children may be more alert to stimuli that are
related to the mother, and may be more likely to have a
smaller attention span when the mother is involved.
During the task, children are shown a picture of either
their mother or an unfamiliar woman, as well as a dark
dot that appears either close to the picture or further
away. Children have to report on whether the woman
was their mother or the unfamiliar woman, and must
then identify where the dot appeared. For further
details and specifications, see [60]. Attentional Narrow-
ing Indices (ANI) are presumed to be a proxy for impli-
cit attachment security and can be derived from the
child’s reaction times (ANI = stimulus close to picture –
stimulus far from picture).
The Five Minute Speech Sample [61] is used to assess
perceived expressed emotion by the father and the
mother. Each parent is asked to talk for five minutes
about his or her child and the relationship they have with
their child. After coding the text, two components can bederived: criticism (CRIT) and emotional overinvolvement
(EOI).
Measures on parental well-being and psychopathology
The WMH Survey version of the World Health
Organization (WHO) Composite International Diag-
nostic Interview WMH-CIDI, now CIDI 3.0; [62] is a
comprehensive, fully-structured interview designed to
be used by trained lay interviewers for the assessment
of mental disorders according to the definitions and
criteria of DSM-IV [41]. We used the Dutch transla-
tion [63] in a computerized version, containing of the
following sections: Depression, Mania, Panic Disorder,
Social Phobia, Separation Anxiety Disorder, Specific
Phobia, Generalized Anxiety Disorder, Obsessive Com-
pulsive Disorder.
The Alcohol Use Disorders Identification Test
[64,65] was developed by the World Health Organization
(WHO) as a simple method of screening for excessive
drinking. Seven of its items reflect harmful and
dependent drinking, while three items assess alcohol con-
sumption behaviour in terms of quantity and frequency
of drinking.
The Positive and Negative Affect Schedule (PANAS)
is a 20-item self-report measure of positive and negative
affect [66]. Negative Affect and Positive Affect reflect
dispositional dimensions, with high NA epitomized by
subjective distress and unpleasurable engagement, and
low NA by the absence of these feelings. By contrast, PA
represents the extent to which an adults experiences
pleasurable engagement with the environment.
Sample size calculation
Our sample size calculation is based on the conven-
tional significance (alpha) and power (1-beta) levels of
0.05 and 0.80 respectively, planning one-sided testing.
We assume a baseline incidence rate of mood and anx-
iety disorders of 0.11/person*year for the control condi-
tion, based on our own unpublished analyses in high
risk offspring from the ARIADNE study; in the ultra-
high risk subgroup of children with 2 or 3 risk factors
we found a 10-year cumulative incidence of anxiety-
and mood-disorders of 0.67 (time frame: age 10–20),
which corresponds to an incidence rate of 0.11/person*-
year, assuming a constant rate. With an intended follow-
up duration of 2 years, we would then need a minimum
of 81 participants per condition to give our study suffi-
cient power to detect a clinically meaningful effect of the
intervention on the time to onset of episodes of mood-
and anxiety disorders. We compared our estimated inci-
dence rates with two prevention studies. Clarke et al.
[13], who studied the effect of a preventive program in
subsyndromal offspring of depressed patients, found a
1 year cumulative incidence of 0.25 for depression alone
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sumption is relatively conservative. We assume a risk re-
duction of 70% for the treatment condition, based on the
Clarke study; the 1 year cumulative incidence of depres-
sion in the intervention group is 0.08, compared to 0.25
in the control group (unadjusted hazard ratio 0.29). The
reported adjusted hazard ratio in this study is 0.18.
Dadds et al. [67] report a hazard ratio of 0.22 in favor of
a program aimed at preventing anxiety disorders in chil-
dren. Again, we choose the more conservative estimate.
Nevertheless, realizing that above-mentioned assump-
tions remain uncertain and that participants may drop
out, we decided to include another 25%, resulting in 2
groups of 102 children for the intervention phase
(N= 204).
Including 554 children for the screening (T0), we esti-
mate that 388 children will be in the ultra high risk group
(70%) and 166 children in the no ultra high risk group
(30%). We anticipate 20% of the eligible children to already
suffer from a mental disorder that warrants treatment, and
another 20% to not want to participate in the intervention
phase of the study for various reasons (leaving N=204 for
randomization). In order to include 554 children in the
screening, we anticipate that we need to select 2770 adult
patient files (80% no children in the right age range or no
interest in participating in the study). This percentage was
based on our earlier experience with the epidemiological
ARIADNE study, following offspring over time.Statistical analyses
Survival analysis will be used to answer the first research
question (effect of treatment on the possible onset of de-
pression or anxiety disorder). It encompasses a wide variety
of methods for analyzing the timing of events. The logrank
test (sometimes called the Mantel-Cox test) is a hypothesis
test and will be used to compare the ‘survival’ distribution
between the intervention and the control group. The meas-
urement is the time to event (clinical onset of anxiety dis-
order or depression). Therefore ‘survival’ is ‘no onset of an
anxiety or mood disorder’ in the study period of 2 years.
All data will be analyzed using the intent-to-treat
principle. Multilevel analysis is a general term referring
to statistical methods appropriate for the analysis of data
sets comprising several types of units of analysis. Multi-
level analysis holds two important features that are rele-
vant to our data, namely the handling of missing data, as
well as the possibility to work with dependent data. In
our case, siblings are dependent (“nested”) data and can
be analyzed as such. Intention to treat analyses are done
to avoid the effects of crossover and drop-out, which
may break the randomization to the treatment groups in
the study. Mediators and moderators can be included as
explanatory variables into the multilevel model.Economic evaluation
An economic evaluation will be conducted alongside the
current study to assist future policy making and resource
allocation. The economic evaluation focuses on the bal-
ance between costs and health outcomes of the treatment
conditions. Both short-term and long-term consequences
are taken into account.
For the short-term economic analyses, data will be
collected prospectively during the 24 months of this
study. Both a cost-effectiveness and cost-utility analysis
will be conducted to provide information on the short-
term economic outcomes. In the cost-effectiveness ana-
lysis, the incremental costs per depression & anxiety-
free year gained are assessed. The cost-utility analysis
will provide information on the incremental costs per
Quality Adjusted Life Year (QALY) gained. QALYs will
be derived from the EQ-5D [46], which is a brief instru-
ment commonly used in economic evaluations. Since
the economic evaluation is conducted from a societal
perspective, both medical costs and costs outside the
healthcare sector will be assessed. Costs and health
outcomes will be discounted in accordance with Dutch
guidelines. Bootstrap analyses are planned to provide
information on the uncertainty surrounding the eco-
nomic results. Subsequently, cost-effectiveness accept-
ability curves will be used to inform decision-makers on
the probability that the intervention is cost-effective.
We will also conduct a long-term analysis. The rela-
tively short follow-up period of the prospective part of
the study has the drawback of potential underestimation
of future beneficial effects of the program. In the pro-
posed long-term analysis we will use decision analytic
modeling to explore the cost-effectiveness of the program
with a longer time horizon (10 yrs). Primary data from
the trial will be combined with secondary data sources,
parameter-estimates from the literature, and where ne-
cessary other sources such as expert opinions. Where
needed, meta-analyses will be performed to aggregate
available literature data. A Markov-type decision model
will be used in the analysis, which is in general well suited
to model chronic diseases, characterized by repeated
relapses and remissions over time. In a Markov- (or
state-transition) model, health states are defined, together
with the probabilities of making the transition from one
health state to another. These models simulate the accu-
mulation of health/quality of life effects and costs over
time under different strategies e.g. [68]. We plan to use
data from NESDA (the Netherlands Epidemiological
Study on Depression and Anxiety [69]), a large ongoing
naturalistic study in patients with mood and anxiety dis-
orders, to model long-term disease history (e.g. to model
duration and frequency of episodes or transitions be-
tween mood- and anxiety disorders). The decision ana-
lysis will also look at long-term productivity effects of the
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a dose-response relationship between number of depres-
sive episodes during adolescence and productivity later in
life. Modeling allows for exploration of cost-effectiveness
of the program under study in different scenarios, e.g. to
model cost-effectiveness under different assumptions
regarding the duration of the treatment effect. Sensitivity
analyses can also be used to reveal the parameters that
are most crucial to the outcome of the study, which will
help to efficiently allocate future research resources.
Ethical approval
The Medical Ethical Committee of the University Med-
ical Center in Groningen gave ethical approval for the
study (nr 2009.200). Multi-center ethical approval was
obtained for the sites in Groningen (UMCG/Accare),
Friesland (GGZ-Friesland), and Leiden (LUMC/Curium-
LUMC).
Discussion
Given the high prevalence of anxiety and mood disorders
in offspring of adults with these disorders, prevention
interventions are needed to prevent internalising mental
disorders in children and adolescents. The current
STERK-study is a randomised controlled prevention trial
in high-risk offspring (aged 8–17 years) of anxious and
depressed patients. We select youth on either elevated
symptoms or on the basis of the High Risk Index that we
developed in an earlier epidemiological offspring study
(ARIADNE). The present study is the first to focus on
both anxiety and depression, since these disorders are
often comorbid, and since epidemiological findings in
offspring show that anxious and depressive symptoms
are prevalent in offspring of patients with anxiety disor-
ders [30] and just as well in patients suffering from uni-
polar depression [31]. With this study, we hope to
contribute to the prevention of mental disorders in off-
spring, as well as to the knowledge on mediators and
moderators of change.
Developing prevention studies, getting funding, gaining
ethical approval, and including participants is a time-
consuming trajectory. For the current study/project, the
grant application was in 2007, the grant was awarded in
2008, and we received ethical approval by the end of
2009. The inclusion of participants into the project is
still ongoing. Due to this timeframe, we have not been
able to incorporate some of the most recent findings into
our design. In fact, the current design is an adaptation of
an earlier design. In the first wave of the study, we only
included adult patients that were currently in treatment,
and we excluded all children with a history of mental ill-
ness. However, we noticed that quite some eligible and
interested participants were excluded in this way. In
addition, the Garber study [14] got published in 2009,showing that prevention interventions may be only fruit-
ful if parents were remitted in terms of their own mental
health problems. Therefore, we decided to broaden the
inclusion scope of our trial (approved of by both the gov-
ernmental funding organization ZonMw and the Medical
Ethical Committee).
A preventive intervention of this kind should not be a
stand-alone in clinical practice. Many youth departments
primarily work on the youth’s psychopathology and
hardly identify parental psychopathology. Likewise, men-
tal health centers for adult patients often do not consider
the mental health status of offspring. During the process
of implementing this study, we noticed that therapists are
often unaware if the adult patient has children. The elec-
tronic patient files usually do not map age or emotional
well being of children. It would be helpful in clinical prac-
tice to pay attention to the psychopathology in the family
as a whole, and to have more cooperation between the
youth and adult departments for cross-referrals. In line
with Garber’s findings it might be helpful to address the
emotional well being of the children in the remitted in-
stead of the acute phase of the parent’s disorder. The
STERK-study may provide valuable tools within such an
infrastructure: a way of screening for high-risk children,
as well as an intervention aiming at symptom reduction
and resilience.
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